ERBB2 and breast cancer: Overall, our breast cancer models can help to get novel mechanistic insights of the context-dependent role of GSDMB in cancer, and the R26-GB2/MMTV-NEU mice can be potentially used in the future to test novel oncologic treatments in HER2-positive tumors.